Establishment Labs Holdings Inc. | Small-cap | Healthcare
$46.11
5.90%
| Establishment Labs Stock Comparison:
Establishment Labs vs Abbott LaboratoriesEstablishment Labs vs Boston ScientificEstablishment Labs vs UFP TechnologiesEstablishment Labs vs Alphatec HoldingsEstablishment Labs vs NovocureEstablishment Labs vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 166.0M
Gross Profit 109.5M 65.97%
Operating Income -50.0M -30.11%
Net Income -84.6M -50.95%

Balance Sheet Metrics

Total Assets 346.8M
Total Liabilities 293.7M
Shareholders Equity 53.1M
Debt to Equity 5.53

Cash Flow Metrics

Operating Cash Flow -72.0M
Free Cash Flow -74.1M

Revenue & Profitability Trend

Establishment Labs Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue166.0M165.2M161.7M126.7M84.7M
Cost of Goods Sold56.5M58.2M55.1M41.3M32.2M
Gross Profit109.5M107.0M106.6M85.4M52.5M
Operating Expenses159.5M172.0M146.3M110.5M80.4M
Operating Income-50.0M-65.0M-39.7M-25.1M-27.9M
Pre-tax Income-84.6M-78.6M-72.8M-39.7M-38.0M
Income Tax-32.0K-81.0K2.4M1.4M104.0K
Net Income-84.6M-78.5M-75.2M-41.1M-38.1M
EPS (Diluted)--$3.07-$3.08-$1.72-$1.63

Income Statement Trend

Establishment Labs Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets243.0M174.9M149.9M113.3M132.3M
Non-Current Assets103.8M93.7M61.2M26.3M24.1M
Total Assets346.8M268.6M211.1M139.5M156.4M
Liabilities
Current Liabilities68.3M57.2M39.0M31.9M25.9M
Non-Current Liabilities225.5M193.1M180.3M56.9M55.5M
Total Liabilities293.7M250.2M219.2M88.8M81.4M
Equity
Total Shareholders Equity53.1M18.4M-8.2M50.7M75.0M

Balance Sheet Composition

Establishment Labs Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-84.6M-78.5M-75.2M-41.1M-38.1M
Operating Cash Flow-72.0M-87.9M-72.8M-34.8M-19.8M
Investing Activities
Capital Expenditures-6.1M-7.9M-2.9M-2.4M-2.1M
Investing Cash Flow-6.2M-7.9M-3.4M-2.9M-3.8M
Financing Activities
Dividends Paid-----
Financing Cash Flow123.4M84.1M96.4M-531.0K63.4M
Free Cash Flow-74.1M-113.1M-86.4M-34.3M-16.4M

Cash Flow Trend

Establishment Labs Key Financial Ratios

Valuation Ratios

Forward P/E -22.17
Price to Book 27.42
Price to Sales 6.21
PEG Ratio -22.17

Profitability Ratios

Profit Margin -52.34%
Operating Margin -40.96%
Return on Equity -186.68%
Return on Assets -11.43%

Financial Health

Current Ratio 3.36
Debt to Equity 585.48
Beta 0.75

Per Share Data

EPS (TTM) -$3.12
Book Value per Share $1.33
Revenue per Share $5.96

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
esta1.1B-27.42-186.68%-52.34%585.48
Abbott Laboratories 231.9B17.314.7530.65%31.89%27.09
Boston Scientific 149.9B73.946.759.50%11.58%52.16
UFP Technologies 1.9B29.895.2019.36%11.59%55.05
Alphatec Holdings 1.6B-9.63-18.581,144.21%-25.77%-6.76
Novocure 1.9B-10.905.12-45.52%-26.41%192.49

Financial data is updated regularly. All figures are in the company's reporting currency.